Zurich, Switzerland

The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists, focusing on using precision medicine to manage patients with HR-positive, HER2-negative metastatic breast cancer. The event is scheduled to take place on March 4–5, 2026, in […]